Dr Fendrick opened the conversation with the commonly prescribed DMARDs (disease-modifying antirheumatic drugs). But the group focused particularly on methotrexate, one of the most commonly prescribed ...
Please provide your email address to receive an email when new articles are posted on . The American College of Rheumatology has released its updated treatment guidelines for rheumatoid arthritis, ...
Please provide your email address to receive an email when new articles are posted on . Maximizing the disease-modifying benefits of methotrexate is one of the core principles behind the 2021 American ...
The American College of Rheumatology (ACR) has issued new guidelines on the treatment of rheumatoid arthritis, addressing questions about initial treatment with methotrexate and minimizing reliance on ...
People taking even low-dose methotrexate need tuberculosis screening and ongoing clinical care if they live in areas where TB is common, results of a study presented at ACR Convergence 2020 suggests.
Vienna, Austria - Patients with rheumatoid arthritis (RA) who had inadequate response to a first course of methotrexate but have not had major toxicity may be good candidates for a second round of ...
Methotrexate significantly lowers systolic blood pressure in newly diagnosed RA patients compared to sulfasalazine, potentially reducing cardiovascular risk. The study provides prospective comparative ...
Older patients with chronic kidney disease (CKD) had greater risks for serious adverse events when starting on low-dose methotrexate rather than hydroxychloroquine, a propensity score-matched analysis ...
New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that tuberculosis (TB) screening and ongoing clinical care is needed for people on methotrexate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results